EGFR and cancer: More novel cancer therapeutics, such as targeted therapies [e.g., epidermal growth factor receptor (EGFR) inhibitors and tyrosine kinase inhibitors (TKI)] and emerging immunotherapies, have also demonstrated oral side effects [7–9].